SP1 |
|
|
ESCC: Upregulated20
|
ESCC: Expression associated with LNM and TNM staging20
|
|
|
Stomach: Peptic cells of the stomach fundus36
|
Stomach: Promotes production of REG1 under stress-induced damage255; Stimulates the production of chromogranin A (CgA)38
|
Gastric cancer: Upregulated40, 41
|
Gastric cancer: Promotes cell invasion42
|
|
|
Pancreas: Acinar cells154, 162
|
Maintains acinar cell function by promoting expression of PTF1A154; Inhibits acinar cell proliferation by interacting with MIST1162
|
PDAC: Upregulated85
|
Regulates mucin production163-165; Regulates expression of KRT19 with KLF422
|
|
|
Pancreas: Beta cells155-157
|
Regulates expression of vesicular glucose transporter 2156 and pyruvate carboxylase157, and regulates expression of PDX1 with SP3155
|
Mild fasting hyperglycemia: mutation to the cis-regulatory region in Gck promoter156
|
Mutations cause loss of binding from SP1 to the cis-regulatory element156
|
|
|
Pancreas: Ductal epithelial cells153
|
Regulates expression of secretin receptor gene with SP3153
|
|
|
|
|
Liver192-194
|
Mediates response to oxidative stress192; Maintains expression of protein S193, 194
|
Cirrhotic Liver: Upregulated195
|
Increases fibrosis by increasing COL1AI expression195
|
|
|
|
|
Alcohol-induced liver injury: crosslinking196
|
Cross-linked by tranglutaminase 2 leading to loss of transcription factor function and induction of apoptosis196
|
|
|
|
|
HCC: Upregulated85
|
Promotes tumor invasion and migration through expression of matrix metalloproteinase 2197 and transactivation of CD151198; involved in aberrant histone acetylation199; Promotes proliferation256; Promotes expression of HULC lnRNA, which induces cell proliferation and survival200
|
|
SP2 |
|
|
Gastric cancer: Upregulated43
|
Gastric cancer: Promotes cell proliferation43
|
|
SP3 |
The Gastric epithelium |
Stomach: Promotes production of REG1 under stress-induced damage255
|
Gastric cancer: Expressed but no differential expression pattern noted |
Gastric cancer: Promotes cell invasion45
|
|
|
Intestinal epithelium |
Promotes apoptosis 79, 80; Promotes expression of Na+/H+ exchangers NHEs69-71; Promotes expression of EK176
|
CRC: Expression pattern not noted |
CRC: Promotes cell proliferation, survival, and invasion85; Promotes apoptosis 91
|
|
|
Pancreas: beta cell155
|
Regulate expression of PDX1 with SP1155
|
PDAC: Upregulated85
|
|
|
|
Pancreas: ductal epithelial cell153
|
Regulates expression of SCTR, secretin receptor gene with SP1153
|
|
|
|
|
|
|
HCC: Upregulated85
|
Promotes expression of HULC lnRNA, which increases cell proliferation and survival200
|
|
SP4 |
|
|
CRC: Expression pattern not noted |
CRC: promotes cell proliferation, survival, and invasion85
|
|
|
|
|
PDAC: Upregulated85
|
|
|
|
|
|
HCC: Upregulated85
|
Promotes expression of HULC lnRNA, which increases cell proliferation and survival200
|
|
SP5 |
|
|
Gastric cancer: Upregulated44
|
|
|
|
|
|
CRC: Upregulated44
|
|
|
SP6 |
Low expression in the crypts of the duodenum257
|
|
|
|
|
SP7 |
Stomach: Parietal cells37
|
|
|
|
|
|
Intestines: Differentiated cells37
|
|
|
|
|
SP8 |
ND (not determined) |
|
ND |
|
|
SP9 |
ND |
|
ND |
|
|
KLF1 |
ND |
|
ND |
|
|
KLF2 |
Pancreas190
|
|
PDAC: Downregulated258
|
Inhibits cell proliferation and migration258
|
|
|
Liver222
|
|
Acute Liver Injury: Downregulated223
|
Vasoprotective, promotes autophagy in liver sinusoid endothelial cells223
|
|
|
|
|
Cirrhotic Liver: Downregulated222, 226, 227
|
Protects against endothelial damage, reduce portal hypertension222; Inhibits the activation of HSCs 226, 227
|
|
KLF3 |
ND |
|
ND |
|
|
KLF4 |
Oral Mucosa18
|
|
OSCC: Downregulated in high grade cancer14, 18, 19
|
Has tumor suppressor function18, 19 and has higher expression in low grade OSCC14
|
|
|
Esophagus: Suprabasal layer26
|
Esophagus: Cell differentiation and maturation26
|
Barrett’s esophagus: Overexpressed in BE specimens; |
Barrett’s esophagus: Involved in the metaplasia of squamous epithelium to columnar epithelium29, 30; |
Esophageal squamous carcinoma: Loss of expression in human ESCC specimens32; increased expression observed in advanced stage ESCC31
|
ESCC: Context-dependent functions as an oncoprotein or tumor-suppressor depending on the stage. At early stage, functions as a tumor suppressor and induces cell differentiation 32, 259. At later stage, increased expression was observed31
|
|
|
Stomach: Differentiated mid- to upper part of the epithelium46
|
Stomach: Cell proliferation and cell fate determination47; ghrelin and histamine production46, 48
|
Gastric cancer: Loss of KLF4 expression49, 50
|
Gastric cancer: Functions as a tumor suppressor by inhibiting cell proliferation and inducing apoptosis49, 54
|
|
|
Small and large intestines: Differentiated cells of the small intestinal villi or luminal surface of the colonic epithelium100-103
|
Small and large intestines: Cell cycle regulation100-102; Anti-apoptotic factor97, 98, 103, 104; Cell differentiation96, 99, 107, 112
|
Colorectal cancer: Loss of KLF4 exprssion127-130
|
IBD: protects against DSS-induced colitis; CRC: Functions as a tumor suppressor; Associated with LNM and poor survival129, 130; Regulates cell cycle127, 131; Inhibits cell invasion135; Functions as an oncogenic factor by promoting anti-apoptotic effects in cells with mutant KRASV12 260
|
|
|
Pancreas: Ductal Epithelial Cells22, 176
|
Transactivates KRT19 expression174, 175
|
PDAC: Required for precursor lesion formation during early tumorigenesis; Downregulated in later stages of tumorigenesis171, 172, 177
|
Cell cycle arrest via upregulate p27Kip1 expression171; Inhibits LDHA expression171; Suppresses metastasis171, 172; Required for acinar-to-ductal metaplasia and PanIN formation177
|
|
|
Liver232
|
|
HCC: Downregulated232, 234-236
|
Tumor suppressor by inhibiting migration and invasion232, 234-236
|
|
KLF5 |
Oral Mucosa15
|
|
OSCC: Upregulated15
|
Promotes cancer growth and survival15
|
|
|
Esophagus: Basal (proliferative) layer25
|
Esophagus: Cell proliferation25; cell migration28
|
ESCC: Downregulated33-35
|
ESCC: Inhibits tumor invasion33; Anti-proliferative factor34; Pro-apoptotic factor35
|
|
|
Gastric epithelium56, 57
|
|
Gastric cancer: Upregulated56, 57
|
Gastric cancer: Associated with higher tumor grade LMN, and lower survival rate57; Involved in H pylori-infection mediated gastric-to-intestinal trans-differentiation58, 59
|
|
|
The intestinal epithelium: Expressed in proliferating cells of the crypts24
|
Regulates cell proliferation117, 261; Regulates cell cycle progression139, 146, 262; Promotes cell differentiation and barrier function116; Maintains stem cell markers and functions117, 119, 120; Involved in intestinal epithelial regeneration124, 125; DNA damage repair125
|
IBD: Intestinal epithelial regeneration121-123
|
CRC: Increased cell proliferation139-141; Promotes nuclear translocation of β-catenin and transcriptional functions144, 145; Promotes oncogenic transformation of Lgr5-expressing stem cells138; Mediates the oncogenic functions of KRASV12G146, 147
|
|
|
Pancreas183
|
|
PDAC: Upregulated179-181, 183, 184
|
Promotes cancer cell growth179-181 and cell survival184; Promotes epithelial phenotype183
|
|
|
Liver219
|
|
Non-alcoholic steatohepatitis: Upregulated219
|
Promote triglyceride synthesis by activating PPARG expression219
|
|
KLF6 |
|
|
Gastric cancer: downregulated61, 62; Variant form of KLF6 (KLF6-SV1) expressed64
|
Gastric cancer: Functions as a tumor suppressor by transcriptionally regulating CDKN1A, c-MYC62; Associated with poor cell differentiation, LMN and TNM stage63; KLF6-SV1 functions as an oncogenic factor and dominant negative regulator of full-length KLF664
|
|
|
|
|
CRC: Downregulated or lost148-150
|
|
|
|
Liver201
|
Required for organogenesis of liver191, 201
|
Non-alcoholic steatohepatitis: Upregulated214, 215, 217
|
KLF6-IVS1-27G>A single nucleotide polymorphism is associated with increased SV1 spliced variant, increased steatosis215 and decreased fibrosis214; Increase steatosis by expression of PPARA and PPARG217
|
|
|
|
|
HCC: Full length variant downregulated; SV1 spliced variant upregulated244
|
Full length variant act as a tumor suppressor239,240-244; SV1 variant inhibits tumor suppressor function of full length variant244
|
|
KLF7 |
ND |
|
ND |
|
|
KLF8 |
|
|
Gastric cancer: Upregulated65, 66
|
GC: Associated with poor prognosis, LNM and TNM staging65, 66; Promotes cell proliferation and EMT67, 68
|
|
|
|
|
HCC: Upregulated248
|
Increases tumor invasion248, 249; Promotes cancer cell proliferation and survival248
|
|
KLF9 |
Esophagus263
|
|
ESCC: Downregulated263
|
ESCC: Tumor suppressor; Forced expression inhibits growth, migration, and metastasis263
|
|
|
Small and large intestines: smooth muscle cells126
|
Regulates proliferation and intestinal morphogenesis126
|
CRC: Downregulated152
|
CRC: Prevents tumor formation152
|
|
|
Liver: Hepatocytes206-208
|
Regulates the expression of P450 enzymes important for detoxification207, 208; Has a role in regulating CYP7A in bile acid synthesis206
|
Non-alcoholic steatohepatitis: Upregulated217
|
Activates expression of PPARG, as does KLF6217
|
|
|
|
|
HCC: Downregulated251
|
Tumor suppressor functions through increasing expression of TP53251
|
|
KLF10 |
Pancreas185
|
Islet Cell: Important for maintaining beta-cell mass and function185
|
PDAC: Downregulated170, 252
|
Inhibits cell growth and induces apoptosis in response to TGFB170, 252
|
|
|
|
|
HCC: Downregulated252
|
Mediates the TGFB induced apoptosis252
|
|
KLF11 |
Pancreas: Acinar cells166
|
Promotes acinar cell differentiation and senescence and suppresses oxidative stress response genes166
|
PDAC: Downregulated166, 168, 169
|
Inhibits cell proliferation; induces apoptosis in response to TGFB166, 168, 169
|
|
|
Pancreas: Islet cells187
|
Maintains normal beta-cell function187
|
French mature-onset diabetes of the young; mutations in KLF11 gene187
|
Loss of ability to transactivate PDX1, required for beta-cell function187
|
|
|
|
|
Neonatal diabetes mellitus: Mutation in cis-regulatory element in insulin promoter189
|
Mutation in insulin promoter prevents KLF11 transactivation of the insulin gene189
|
|
|
Liver264
|
|
Non-alcoholic steatohepatitis: Upregulated218
|
Activates expression of PPARA and promotes steatosis218
|
|
|
|
|
Cirrhotic Liver: Upregulated231
|
Directly activates expression of collagen 1a2 and induce fibrosis231
|
|
KLF12 |
ND |
|
ND |
|
|
KLF13 |
ND |
|
ND |
|
|
KLF14 |
Liver: Hepatocytes209, 210
|
Increases signaling lipid production by activating SK1209; Regulates expression of APOAI gene210
|
|
|
|
KLF15 |
Liver: Hepatocytes204, 205
|
Regulates gluconeogenesis by regulating amino acid utilization204 and PEPCK expression205
|
Non-alcoholic steatohepatitis: Upregulated220
|
Promotes steatosis by promoting insulin resistance and lipid accumulation220
|
|
KLF16 |
ND |
|
ND |
|
|
KLF17 |
Esophagus265
|
|
ESCC: Downregulated265
|
ESCC: Decreased expression correlated with metastasis265
|
|
|
|
|
Gastric cancer: Downregulated266
|
Gastric cancer: Associated with tumor size, LMN, and poor survival266
|
|
|
|
|
HCC: Downregulated253, 254
|
Inhibits tumor invasion and migration253, 254
|